Clinical experience using appetite suppressants and SSRIs.
The use of sympathomimetic appetite suppressants and serotonin-selective reuptake inhibitors (SSRIs) has been questioned due to anecdotal reports of serotonin syndrome. This survey of bariatric physicians using these medications in clinical practice did not find any cases of serotonin syndrome among 1174 patients. The monitored use of the combination of these medicines by trained practitioners is justifiable.
Rader
W Alan
WA
Duke University Medical Center, Durham, NC 27704, USA.
Steelman
G Michael
GM
Westman
Eric C
EC
D001067:Appetite Depressants / Q000008:administration & dosage* / Q000627:therapeutic use; D052938:Bariatric Medicine / Q000706:statistics & numerical data*; D004359:Drug Therapy, Combination; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D010645:Phentermine / Q000008:administration & dosage* / Q000627:therapeutic use; D010818:Practice Patterns, Physicians'; D020230:Serotonin Syndrome / Q000139:chemically induced; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D011795:Surveys and Questionnaires
D001067:Appetite Depressants; D010645:Phentermine; D017367:Selective Serotonin Reuptake Inhibitors